Inhibrx, Inc. Common Stock
INBX
INBX was delisted on the 29th of May, 2024.
2 hedge funds and large institutions have $1.16M invested in Inhibrx, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 123 closing their positions.
98% less funds holding
Funds holding: 126 → 2 (-124)
100% less capital invested
Capital invested by funds: $1.34B → $1.16M (-$1.34B)
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 123
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$250M |
| 2 |
PA
Perceptive Advisors
New York
|
-$149M |
| 3 |
BlackRock
New York
|
-$96.2M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$91.9M |
| 5 |
State Street
Boston,
Massachusetts
|
-$84.5M |
INBX Hedge Fund Activity: Q2 2024 in Review
2 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q2 2024, worth a combined $1.16M — down 100% from $1.34B a quarter earlier.
Sellers outnumbered buyers: 123 funds closed out of INBX and 0 opened new positions — a net loss of 123 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Viking Global Investors, exiting entirely with an estimated $250M sold.
- 2 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q2 2024, down from 126 in Q1 2024.
- Funds reported $1.16M of Inhibrx, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
- 0 funds opened new Inhibrx, Inc. Common Stock positions in Q2 2024 and 123 closed out, a net change of -123 holders.
- The largest Inhibrx, Inc. Common Stock seller in Q2 2024 was Viking Global Investors, an estimated $250M sold.
Based on aggregated 13F filings for Q2 2024.